Pharma and Food Thought Leaders Set to Converge in Amsterdam Next April 2011

Aug 20, 2010, 10:29 ET from Elsevier

AMSTERDAM, August 20, 2010 /PRNewswire-FirstCall/ -- Pharma-Nutrition (http://www.pharma-nutrition.com/news.asp), the new international scientific conference organised by Elsevier, the leading publisher of scientific, technical and medical information products and services, aims to discuss the latest research, concepts and practical applications of medical nutrition in patient treatments, disease management and patient outcomes. Pharma-Nutrition is set to take place next 18-20 April at Amsterdam's NH Grand Hotel Krasnapolsky. The convergence of both pharmacology and food science professionals, will make this the first platform dedicated to the scientific interface between pharma and food.

The Scientific Committee composed of acknowledged opinion leaders in both food science and pharmacology from across the spectrum of therapeutic research areas will work alongside organisers to develop a multidisciplinary programme, covering areas such as oncology, immunology, neurology and cardiovascular disease. The Conference Chairman, Professor Johan Garssen, University of Utrecht, commented, "We are starting to see a real convergence of the two areas of pharma and food and it is their complementary values which can be applied to medical nutrition in order to help address the ever growing burden of diseases in modern society."

"I am so pleased that we have been able to bring together for the first time such an outstanding group of preclinical and clinical experts from both pharma and nutrition," said Dr. Jaap van Harten, Elsevier Executive Publisher. "This conference will provide the platform for participants to share and discuss their latest research on this important area of science," he remarked.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet (http://www.thelancet.com) and Cell (http://www.cell.com), and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect (http://www.sciencedirect.com), Scopus (http://www.scopus.com), Reaxys (http://www.reaxys.com), MD Consult (http://www.mdconsult.com) and Nursing Consult (http://www.nursingconsult.com), which enhance the productivity of science and health professionals, and the SciVal suite (http://www.scival.com) and MEDai's Pinpoint Review (http://www.medai.com), which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier ( http://www.elsevier.com) employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC (http://www.reedelsevier.com), a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

    Media Contact

    Rachel Martin
    +31(0)20-485-2467
    r.martin@elsevier.com


SOURCE Elsevier